Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron sucrose versus ferric carboxymaltose for preoperative iron deficiency anemia in cardiac surgery
IRCT20170705034908N3Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of iron sucrose and ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Change in ferritin and Change in hemoglobin. Started Feb 2019; status: completed.
02
Drugs
iron sucroseferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20170705034908N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170705034908N3.